Daratumumab Shows Promise in Early Myeloma Stages
In a groundbreaking advancement in hematological oncology, researchers have unveiled the promising results of the Phase II D-PRISM study, which ...
In a groundbreaking advancement in hematological oncology, researchers have unveiled the promising results of the Phase II D-PRISM study, which ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine